Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXG64D
|
||||
Drug Name |
4-(2-Cyano-benzenesulfonylamino)-N-[1-(2S-ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-benzamide
|
||||
Synonyms |
CHEMBL514299
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H34N4O6S
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4ccccc4C#N)cc3
|
||||
InChI |
InChI=1S/C29H34N4O6S/c1-3-24-26(23(34)18-39-24)32-28(36)22(16-29(2)14-6-7-15-29)31-27(35)19-10-12-21(13-11-19)33-40(37,38)25-9-5-4-8-20(25)17-30/h4-5,8-13,22,24,26,33H,3,6-7,14-16,18H2,1-2H3,(H,31,35)(H,32,36)/t22-,24-,26+/m0/s1
|
||||
InChIKey |
ADSUKSQQYWNBGE-LLZJGCNPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.